Remifentanil Leman IV 1 mg

Remifentanil Leman IV 1 mg is a medicine authorised by Swissmedic under authorisation number 69918. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 19 June 2025 and the authorisation is limited until 18 June 2030. ATC code N01AH06 places the medicine in the group Anesthetics.

  • Dispensing category A+
  • Authorisation number 69918
  • ATC N01AH06
  • Synthetic medicines
Authorisation data
Authorisation number69918
NameRemifentanil Leman IV 1 mg
Full nameRemifentanil Leman IV 1 mg, poudre pour solution à diluer pour perfusion
Authorisation holderLeman SKL SA
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codeN01AH06
First authorisation19 June 2025
Authorisation validity18 June 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Remifentanil Leman IV 1 mg, poudre pour solution à diluer pour perfusionA+19 June 2025
2Remifentanil Leman IV 2 mg, poudre pour solution à diluer pour perfusionA+19 June 2025
3Remifentanil Leman IV 5 mg, poudre pour solution à diluer pour perfusionA+19 June 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15Durchstechflasche(n)N01AH0601.01.3.A+
25Durchstechflasche(n)N01AH0601.01.3.A+
35Durchstechflasche(n)N01AH0601.01.3.A+

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Remifentanil Leman IV 1 mg authorised in Switzerland?

Yes. Remifentanil Leman IV 1 mg is authorised by Swissmedic under authorisation number 69918, data as of 01 September 2026. The authorisation is limited until 18 June 2030.

Which dispensing category does Remifentanil Leman IV 1 mg have?

Remifentanil Leman IV 1 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Remifentanil Leman IV 1 mg?

The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com